Who Paid My Doc
Anusha Devarajan
Sleep Medicine Burlington, VT Medical Doctor
NPI 1639691272 CMS profile 11418630
111 Colchester Ave, Burlington, VT 05401
General payments
$122
Research payments
$0
Ownership & investment interest
$0
Through program year 2022, Anusha Devarajan of Burlington, VT is reported in the CMS Open Payments database as having received $122 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 14th percentile of Sleep Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2022 | General | $122 | 1 |
Beside peers
- Anusha Devarajan
- Sleep Medicine median
- Middle half of Sleep Medicine
- National median
In program year 2025, general payments to Anusha Devarajan were reported at $0. Among 670 Sleep Medicine profiles paid that year, the median was $439 and the middle half received between $127 and $1,274.
Show as a table
| Year | Anusha Devarajan | Sleep Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $185 | $66–$736 | $163 |
| 2020 | $0 | $149 | $46–$504 | $114 |
| 2021 | $0 | $191 | $62–$750 | $132 |
| 2022 | $122 | $246 | $92–$972 | $149 |
| 2023 | $0 | $321 | $119–$1,033 | $160 |
| 2024 | $0 | $393 | $111–$1,207 | $164 |
| 2025 | $0 | $439 | $127–$1,274 | $169 |
Breakdown
Billing to Medicare
Part B · data year 2024 · 19 billing codesPaid by Medicare
$8,831
Medicare patients
72
Services billed
112
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 65% | |
| Diabetes | 39% | |
| COPD | 36% | |
| Ischemic heart disease | 33% | |
| Atrial fibrillation | 33% | |
| Depression | 33% | |
| Arthritis | 33% | |
| Heart failure | 29% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
Sleep Medicine in Vermont
Practitioners in the same specialty and state, ranked by reported value.
All Sleep Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Vermont
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.